Synthesis of Fatty Acid Amides of Catechol Metabolites that Exhibit Antiobesity Properties-Reference-Cited by-同舟云学术

Synthesis of Fatty Acid Amides of Catechol Metabolites that Exhibit Antiobesity Properties

Published:2010-08-18 Issue:10 Volume:5 Page:1781-1787
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Almeida Bruno,Joglar Jesús,Luque Rojas María Jesús,Decara Juan Manuel,Bermúdez-Silva Francisco Javier,Macias-González Manuel,Fitó Montserrat,Romero-Cuevas Miguel,Farré Magí,Covas María Isabel,Rodríguez de Fonseca Fernando,de la Torre Rafael

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Reference31 articles.

1. Chapter 8 Novel Endogenous N‐Acyl Glycines

2. Conversion of Acetaminophen to the Bioactive N-Acylphenolamine AM404 via Fatty Acid Amide Hydrolase-dependent Arachidonic Acid Conjugation in the Nervous System

3. Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia

4. The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors

5. CANNABINOID RECEPTORS AS THERAPEUTIC TARGETS

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydroxytyrosol Linoleoyl Ether Ameliorates Metabolic-Associated Fatty Liver Disease Symptoms in Obese Zucker Rats;ACS Pharmacology & Translational Science;2024-04-04

2. Relevance of Peroxisome Proliferator Activated Receptors in Multitarget Paradigm Associated with the Endocannabinoid System;International Journal of Molecular Sciences;2021-01-20

3. PPARα/CB1 receptor dual ligands as a novel therapy for alcohol use disorder: Evaluation of a novel oleic acid conjugate in preclinical rat models;Biochemical Pharmacology;2018-11

4. Pharmacological Aspects of Novel Antiobesity Agents Related to Cannabinoids;Handbook of Cannabis and Related Pathologies;2017

5. Treatment with a novel oleic-acid–dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats;Disease Models & Mechanisms;2015-10-01